Format

Send to

Choose Destination
World J Hepatol. 2015 Jun 8;7(10):1369-76. doi: 10.4254/wjh.v7.i10.1369.

Non-alcoholic fatty liver disease - the heart of the matter.

Author information

1
Haneen Azzam, Stephen Malnick, Department of Internal Medicine C, Kaplan Medical Center, Rehovot 76100, Israel.

Abstract

Non-alcoholic fatty liver disease (NAFLD) is one of the most common forms of chronic liver disease in the Western world. There is a close association with the metabolic syndrome and NAFLD is considered to be the hepatic manifestation of the metabolic syndrome. The components of the metabolic syndrome include hypertension, obesity and insulin resistance which are well established cardiovascular risk factors. The mortality rate of NAFLD patients from myocardial infarction is higher than that in the general United States population and there is also an increased risk of non-fatal cardiovascular events. This article reviews the cardiovascular complications associated with NAFLD. In order to provide comprehensive care of NAFLD patients, physicians need to be aware of, and search for, the cardiac morbidity associated with NAFLD.

KEYWORDS:

Cardiovascular; Diastolic dysfunction; Non-alcoholic fatty liver disease; Palatin-like phospholipase domain containing 3 gene; Sleep apnea

Supplemental Content

Full text links

Icon for Baishideng Publishing Group Inc. Icon for PubMed Central
Loading ...
Support Center